
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [NVO] Novo Nordisk
Data updated 2025-May-02 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-May-02 Friday
Open | $69.75 | High | $69.86 +0.16% |
---|---|---|---|
Close | $69.23 | Low | $68.53 -1.75% |
Volume | 13.4 Million 1.06x | Volatility | 1.94% |
Change |
+$3.63
+5.53%
|
Streak | ↑ 1 days +5.53% |
20d SMA | $63.18 +9.6% | 50d SMA | $73.18 -5.4% | 100d SMA | $81.14 -14.7% | 200d SMA | $101.59 -31.9% |
RSI | 56 | MACD | 1.42 | ADX | 30.9 | Stochastic Oscillator | 88.2 84.0 |
CCI | 199.5 | ATR | 2.91 | OBV | 352 Million | Chaikin A/D | 912 Million |
Market Cap | 565 B | PEG Ratio | 2.44 | Trailing P/E | 47.1 | Forward P/E | 38.2 |
Price/Sales (ttm) | 17 | Price/Book (mrq) | 36.7 | EV/Revenue (ttm) | 2.43 | EV/EBITDA (ttm) | 4.92 |
% Held by Insiders | 0.00% | % Held by Institutions | 9.27% | Shares Short | 4.11 M | Shares Short (prior month) | 4.67 M |
Short Ratio | 0.88 | Short % of Outstanding | 0.09% | Short % of Float | 0.13% | Shares Short Change (mom) | -12.0% |
Revenue/Share (ttm) | $51.81 | Profit Margin (ttm) | 36.03% | Operating Margin (ttm) | 42.79% | EBITDA (ttm) | 110 B |
Diluted EPS (ttm) | $2.70 | Current Ratio (mrq) | 0.82 | Return on Assets (ttm) | 23.39% | Return on Equity (ttm) | 88.07% |
Qtr Earnings Growth (yoy) | 61.60% | Qtr Revenue Growth (yoy) | 37.00% | Operating Cash Flow (ttm) | 109 B | Free Cash Flow (ttm) | 54.1 B |
Choose view type
Daily Performance for Novo Nordisk. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Novo Nordisk up to close of 2025-May-02 at $69.23
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+11.52%
|
-0.9%
|
+11.7%
|
12.7%
|
+5.2%
|
+4.6%
|
1.06x
|
02 Trailing 10-days
|
|
+19.20%
|
-0.9%
|
+21.5%
|
22.6%
|
+9.3%
|
+6.8%
|
0.94x
|
03 Trailing 20-days
|
|
+3.17%
|
-0.9%
|
+21.5%
|
22.6%
|
+9.6%
|
+6.1%
|
1.25x
|
04 Trailing 30-days
|
|
-12.13%
|
-10.4%
|
+21.5%
|
35.6%
|
+5.2%
|
+3.2%
|
1.10x
|
05 Trailing 50-days
|
|
-17.33%
|
-26.2%
|
+21.5%
|
64.6%
|
-5.4%
|
-2.8%
|
1.00x
|
06 Trailing 100-days
|
|
-36.38%
|
-38.5%
|
+21.5%
|
97.4%
|
-14.7%
|
-14.4%
|
1.32x
|
07 Trailing 200-days
|
|
-50.86%
|
-50.5%
|
+21.5%
|
145.2%
|
-31.9%
|
-25.2%
|
1.10x
|
08 Month-to-date
|
|
+4.18%
|
-0.9%
|
+7.9%
|
8.9%
|
|
|
|
09 Quarter-to-date
|
|
-0.30%
|
-1.1%
|
+21.5%
|
22.8%
|
|
|
|
10 Year-to-date
|
|
-19.52%
|
-26.2%
|
+21.5%
|
64.6%
|
|
|
|
11 Trailing 52-weeks
|
|
-44.18%
|
-53.3%
|
+21.5%
|
159.9%
|
|
|
|
6-month Performance Benchmarks for Novo Nordisk:
Related to Novo Nordisk
Information for Novo Nordisk
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-02 on Google
SEC Reports : Quarterly reports around 2025-May-02 on SEC Edgar
Compare Novo Nordisk with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Novo Nordisk
Industry : Pharmaceuticals industry performance which includes Novo Nordisk